Showing results (191-200 of 330) with videos related to
Sort By:
Pageof 33
International Journal of Cancer|October 15, 1988
Liposoluble vitamins and lipid parameters in breast cancer. A joint study in northern Italy and southern FranceM Gerber, F Cavallo, E Marubini, et al.World Journal of Surgery|March 30, 2013
Early structured surgical management plan for neonates with short bowel syndrome may improve outcomesS J Wood, B Khalil, F Fusaro, et al.The British Journal of Surgery|March 1, 1995
Morbidity and mortality after hepatic resection of metastases from colorectal cancerR Doci, L Gennari, P Bignami, et al.Il Giornale Di Chirurgia|May 1, 1995
[Peripheral nerve tumors of the thoracic wall: 2 case reports]R Cristofani, M F Burattini, P Campi, et al.American Journal of Obstetrics and Gynecology|August 15, 1998
Which cutoff level should be used in screening for glucose intolerance in pregnancy? Definition of Screening Methods for Gestational Diabetes Study Group of the Lombardy Section of the Italian Society of DiabetologyM Bonomo, M L Gandini, A Mastropasqua, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 6, 2006
Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancerU Veronesi, L Mariani, A Decensi, et al.The Journal of Urology|June 1, 1981
Anatrophic nephrolithotomy: preservation of renal function demonstrated by differential quantitative radionuclide renal scansJ A Belis, R A Morabito, S J Kandzari, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variablesS Ménard, P Valagussa, S Pilotti, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Long-term tolerability of fenretinide (4-HPR) in breast cancer patientsN Rotmensz, G De Palo, F Formelli, et al.Pageof 33